Korea Investment CORP lowered its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 9.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 812,447 shares of the healthcare conglomerate’s stock after selling 87,360 shares during the period. UnitedHealth Group accounts for approximately 1.0% of Korea Investment CORP’s investment portfolio, making the stock its 13th biggest holding. Korea Investment CORP owned approximately 0.08% of UnitedHealth Group worth $216,143,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Welch Group LLC bought a new position in UnitedHealth Group during the 2nd quarter worth $106,000. FNY Investment Advisers LLC bought a new position in UnitedHealth Group during the 3rd quarter worth $106,000. Fort L.P. bought a new position in UnitedHealth Group during the 2nd quarter worth $119,000. Polaris Greystone Financial Group LLC bought a new position in UnitedHealth Group during the 3rd quarter worth $120,000. Finally, Columbia Asset Management bought a new position in UnitedHealth Group during the 3rd quarter worth $152,000. Institutional investors own 85.57% of the company’s stock.
Several brokerages have recently issued reports on UNH. Jefferies Financial Group lifted their price target on UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research note on Wednesday, October 3rd. Argus lifted their price target on UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research note on Thursday, October 18th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $292.00 price target on the stock in a research note on Monday, November 26th. Morgan Stanley lifted their price target on UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research note on Wednesday, September 5th. Finally, ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Tuesday, October 2nd. Two analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $292.48.
In other UnitedHealth Group news, CEO Steven H. Nelson sold 26,033 shares of UnitedHealth Group stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $270.65, for a total transaction of $7,045,831.45. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Kenneth Irwin Shine sold 163 shares of UnitedHealth Group stock in a transaction dated Friday, November 9th. The stock was sold at an average price of $274.83, for a total value of $44,797.29. The disclosure for this sale can be found here. In the last three months, insiders have sold 60,428 shares of company stock worth $16,232,134. 0.87% of the stock is currently owned by company insiders.
NYSE UNH opened at $278.55 on Thursday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69. UnitedHealth Group Inc has a twelve month low of $208.48 and a twelve month high of $287.94. The firm has a market cap of $270.68 billion, a P/E ratio of 27.66, a PEG ratio of 1.65 and a beta of 0.76.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The company had revenue of $56.56 billion for the quarter, compared to the consensus estimate of $56.34 billion. During the same quarter last year, the business posted $2.66 EPS. UnitedHealth Group’s revenue for the quarter was up 12.4% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group Inc will post 12.82 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Investors of record on Monday, December 3rd will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.29%. The ex-dividend date of this dividend is Friday, November 30th. UnitedHealth Group’s dividend payout ratio (DPR) is 35.75%.
TRADEMARK VIOLATION NOTICE: “Korea Investment CORP Sells 87,360 Shares of UnitedHealth Group Inc (UNH)” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/12/06/korea-investment-corp-sells-87360-shares-of-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Systematic Risk and Investors
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.